Larotrectinib Capsules and Novo-Clavamoxin 125
Determining the interaction of Larotrectinib Capsules and Novo-Clavamoxin 125 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
Generic Name: amoxicillin / clavulanate
Brand name: Augmentin, Augmentin ES-600, Augmentin XR
Synonyms: Amoxicillin and Clavulanate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Larotrectinib Capsules-Novo-Clavamoxin 250
- Larotrectinib Capsules-Novo-Furan Suspension
- Larotrectinib Capsules-Novo-Hydrocort Cream Topical application
- Larotrectinib Capsules-Novo-Hydrocort Topical application
- Larotrectinib Capsules-Novo-Lexin
- Larotrectinib Capsules-Novo-Methacin Suppositories
- Novo-Clavamoxin 125-Larotrectinib Oral Solution
- Novo-Clavamoxin 125-Larotrectinib Sulfate
- Novo-Clavamoxin 125-Lartruvo
- Novo-Clavamoxin 125-Larynex
- Novo-Clavamoxin 125-Laryng-O-Jet
- Novo-Clavamoxin 125-Laryngesic